RESHAPE LIFESCIENCES INC (RSLS)

US76090R2004 - Common Stock

4.38  -0.09 (-2.01%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
13.6M
755.35%
11.24M
-17.35%
8.678M
-22.79%
10.194M
17.47%
12.233M
20.00%
EBITDA
YoY % growth
-25.26M
-145.24%
-24.93M
1.31%
-14.485M
41.90%
N/AN/A
EBIT
YoY % growth
-27.23M
-155.92%
-27.08M
0.55%
-14.639M
45.94%
-6.844M
53.25%
-5.934M
13.29%
Operating Margin
-200.22%-240.93%-168.69%-67.14%-48.51%
EPS
YoY % growth
N/A
37.13%
-4,732.22
45.58%
-205.92
95.65%
-0.46
99.78%
-0.37
20.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth
-0.07
98.88%
Revenue
Q2Q % growth
3.236M
63.27%
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
-1.179M
37.78%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth

99.78%
-0.10%
Q2 2024
Q2Q % growth

99.80%
-0.12%
Q1 2024
Q2Q % growth
-5.22
94.23%
-9.474.2544.85%
Q4 2023
Q2Q % growth
-6.40
98.72%
-10.654.2539.93%
Q3 2023
Q2Q % growth
-46.40
96.92%
-70.9924.5934.64%
Q2 2023
Q2Q % growth
-62.64
95.68%
-105.9043.2640.85%
Q1 2023
Q2Q % growth
-90.48
92.91%
-249.06158.5863.67%
Q4 2022
Q2Q % growth
-498.22
68.19%
-591.6093.3815.78%
Q3 2022
Q2Q % growth
-1,508.00
64.86%
-1,050.09-457.91-43.61%
Q2 2022
Q2Q % growth
-1,450.00
-308,410.64%
-1,064.88-385.12-36.17%
Q1 2022
Q2Q % growth
-1,276.00
-182,185.71%
-1,020.51-255.49-25.04%
Q4 2021
Q2Q % growth
-1,566.00
-5.88%
-517.65-1,048.35-202.52%
Q3 2021
Q2Q % growth
-4,292.00
-146.67%
-443.70-3,848.30-867.32%
Q2 2021
Q2Q % growth
-0.47
99.99%
-0.34-0.13-39.63%
Q1 2021
Q2Q % growth
-0.70
99.99%
-0.54-0.16-29.49%
Q4 2020
Q2Q % growth
-1,479.00
73.44%
-532.44-946.56-177.78%
Q3 2020
Q2Q % growth
-1,740.00
67.21%
-621.18-1,118.82-180.11%
Q2 2020
Q2Q % growth
-4,698.00
78.40%
-2,662.20-2,035.80-76.47%
Q1 2020
Q2Q % growth
-5,916.00
81.11%
-4,525.74-1,390.26-30.72%
Q4 2019
Q2Q % growth
-5,568.00
83.59%
-5,146.92-421.08-8.18%
Q3 2019
Q2Q % growth
-5,307.00
82.57%
-19,034.7313,727.7372.12%
Q2 2019
Q2Q % growth
-21,750.00
56.14%
-21,593.10-156.90-0.73%
Q1 2019
Q2Q % growth
-31,320.00
43.75%
-32,833.801,513.804.61%
Q4 2018
Q2Q % growth
-33,930.00 -31,946.40-1,983.60-6.21%
Q3 2018
Q2Q % growth
-30,450.00 -42,299.7011,849.7028.01%
Q2 2018
Q2Q % growth
-49,590.00 -45,257.40-4,332.60-9.57%
Q1 2018
Q2Q % growth
-55,680.00 -44,591.85-11,088.15-24.87%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
2.292M
6.36%
2.558M-266K-10.40%
Q2 2024
Q2Q % growth
1.965M
-12.82%
2.253M-288K-12.78%
Q1 2024
Q2Q % growth
1.944M
-15.00%
2.146M-202K-9.41%
Q4 2023
Q2Q % growth
1.982M
-36.27%
2.252M-270K-11.99%
Q3 2023
Q2Q % growth
2.155M
-23.04%
2.448M-293K-11.97%
Q2 2023
Q2Q % growth
2.254M
-22.01%
2.662M-408K-15.33%
Q1 2023
Q2Q % growth
2.287M
-6.27%
2.563M-276K-10.77%
Q4 2022
Q2Q % growth
3.11M
-0.96%
3.165M-55K-1.74%
Q3 2022
Q2Q % growth
2.8M
-24.53%
3.689M-889K-24.10%
Q2 2022
Q2Q % growth
2.89M
-18.13%
3.477M-587K-16.88%
Q1 2022
Q2Q % growth
2.44M
-24.22%
3.287M-847K-25.77%
Q4 2021
Q2Q % growth
3.14M
5,133.33%
3.814M-674K-17.67%
Q3 2021
Q2Q % growth
3.71M
9,175.00%
3.947M-237K-6.00%
Q2 2021
Q2Q % growth
3.53M
404.29%
3.876M-346K-8.93%
Q1 2021
Q2Q % growth
3.22M
312.82%
3.248M-27.999K-0.86%
Q4 2020
Q2Q % growth
60K
-92.41%
60K%
Q3 2020
Q2Q % growth
40K
-87.88%
40K%
Q2 2020
Q2Q % growth
700K
79.49%
700K%
Q1 2020
Q2Q % growth
780K
-56.18%
714K66K9.24%
Q4 2019
Q2Q % growth
790K
-61.27%
471.75K318.25K67.46%
Q3 2019
Q2Q % growth
330K
-88.96%
1.224M-894K-73.04%
Q2 2019
Q2Q % growth
390K
-85.71%
1.784M-1.394M-78.14%
Q1 2019
Q2Q % growth
1.78M
31.85%
1.718M62K3.61%
Q4 2018
Q2Q % growth
2.04M 2.167M-127K-5.86%
Q3 2018
Q2Q % growth
2.99M 2.558M432K16.89%
Q2 2018
Q2Q % growth
2.73M 3.322M-592K-17.82%
Q1 2018
Q2Q % growth
1.35M 3.533M-2.183M-61.79%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
Revenue0% 0% 0% 0%